TGFB1 and acute myeloid leukemia: Similarly, a significant difference was observed in TGF-β levels between the AML group (5.098 ± 1.522 ng/mL) and the control group (2.306 ± 0.471 ng/mL) (p < 0.01, Fig. 4b).